Provided by Tiger Trade Technology Pte. Ltd.

ENGENE HOLDINGS INC

1.85
+0.03501.93%
Volume:771.33K
Turnover:1.44M
Market Cap:123.59M
PE:-0.87
High:1.89
Open:1.85
Low:1.82
Close:1.81
52wk High:12.25
52wk Low:1.40
Shares:66.98M
Float Shares:32.73M
Volume Ratio:2.69
T/O Rate:2.36%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.1229
EPS(LYR):-2.2947
ROE:-52.58%
ROA:-28.86%
PB:0.48
PE(LYR):-0.80

Loading ...

enGene Therapeutics Inc - 55% Experienced Treatment-Related Adverse Events of Detalimogene, Mostly Mild

THOMSON REUTERS
·
May 07

H.C. Wainwright Keeps Their Buy Rating on enGene Holdings (ENGN)

TIPRANKS
·
Apr 29

enGene Holdings Initiated at Buy by WBB Securities

Dow Jones
·
Apr 14

enGene Holdings changes name to enGene Therapeutics as it eyes 2027 launch

Reuters
·
Apr 10

BRIEF-Engene Holdings Inc - To Change Name To Engene Therapeutics Inc. Effective April 8, 2026

Reuters
·
Apr 07

enGene Holdings Inc - Planned Bla Submission for Detalimogene in Second Half of 2026

THOMSON REUTERS
·
Apr 07

enGene Holdings Inc - to Change Name to enGene Therapeutics Inc. Effective April 8, 2026

THOMSON REUTERS
·
Apr 07

enGene Holdings changes name to enGene Therapeutics effective April 8, 2026

Reuters
·
Apr 07

Three new option listings and three option delistings on April 6th

TIPRANKS
·
Apr 06

enGene price target lowered to $9 from $10 at UBS

TIPRANKS
·
Mar 22

Analysts Offer Insights on Healthcare Companies: enGene Holdings (ENGN) and Boston Scientific (BSX)

TIPRANKS
·
Mar 22

enGene Holdings Inc. : Oppenheimer Cuts Target Price to $30 From $33

THOMSON REUTERS
·
Mar 11

enGene Holdings (ENGN) Gets a Buy from Wells Fargo

TIPRANKS
·
Mar 10

enGene price target lowered to $27 from $30 at Guggenheim

TIPRANKS
·
Mar 10

enGene Holdings Price Target Maintained With a $25.00/Share by HC Wainwright & Co.

Dow Jones
·
Mar 10

enGene Holdings Inc reports results for the quarter ended January 31 - Earnings Summary

Reuters
·
Mar 09

BRIEF-Engene Holdings Enters Sales Agreement With Leerink Partners To Sell Common Shares

Reuters
·
Mar 09

enGene Holdings Q1 EPS $(0.44) Beats $(0.58) Estimate

Benzinga Earnings
·
Mar 09

enGene Holdings Inc - Enters Sales Agreement With Leerink Partners to Sell Common Shares - SEC Filing

THOMSON REUTERS
·
Mar 09

enGene Q1 net loss attributable to common shareholders rises 21% to USD 29.75 million on 17% higher operating expenses of USD 31.19 million

Reuters
·
Mar 09